INC Research Continues Strong Support for Site Relationships at 2015 SCRS Global Site Solutions Summit

RALEIGH, N.C., Oct. 07, 2015 (GLOBE NEWSWIRE) -- INC Research Holdings, Inc. (Nasdaq:INCR), a leading, global Phase I to IV contract research organization, today announced an extensive presence and several key activities planned for the Society for Clinical Research Sites' (SCRS) 10th Annual Global Site Solutions Summit Oct. 8-11 in Amelia Island, Fla. The Company will kick off its participation with CEO Jamie Macdonald delivering the summit’s first plenary session, “Collaborating for the Future: Developing Effective CRO, Site and Sponsor Relationships in a Changing Healthcare Environment.” Additional INC Research clinical development executives will participate in six different sessions on key issues facing the site community and will be on hand at Booth #33/34 to engage in an active dialogue regarding how CROs and sites can collaborate more effectively for the benefit of patients.

"Motivated, high-quality sites are essential to conducting clinical research," said CEO Jamie Macdonald. "The SCRS Site Solutions Summit provides a tremendous opportunity to connect with our site partners, demonstrate our appreciation for the enormous contributions they make to clinical research and gain their insights and perspective to improve the clinical development process and ultimately the patient experience. Congratulations to SCRS for its 10th year in producing such as important program for sites, CROs and sponsors to explore best practices for collaboration in clinical research.”

Connecting with sites at Booth 33/34 and at key sessions throughout the conference
INC Research thought leaders will be available throughout the summit at Booth #33/34 and will present at the following sessions:

  • Jamie Macdonald, Chief Executive Officer

“Collaborating for the Future: Developing Effective CRO, Site and Sponsor Relationships in a Changing Healthcare Environment”
Friday, Oct. 9 (4:10-4:45 p.m.)

  • Christine Phillips, PhD, Director, Site and Patient Access

“Social Media: Panacea or Panic?”
Saturday, Oct. 10 (1:00-2:00 p.m.)

  • Jill Collins, Executive Director, Clinical Innovation

“Data That Matters: Identify the Process for Looking at Protocols through the RBM Model”
Saturday, Oct. 10 (1:00-2:00 p.m.)

  • Clare Grace, PhD, Vice President, Site and Patient Access

“Preferred Partnerships: What's It All About?”
Saturday, Oct. 10 (1:00-2:00 p.m.)

  • Shannon Kellner, Associate Director, Global Feasibility

“Feasibility: How to Build Credibility by Accurately Predicting Enrollment Rates and Sharing Metrics”
Saturday, Oct. 10 (1:00-2:00 p.m.)

  • Carol Aliyar, Senior Vice President and Global Head, Study Start-up

“Alternative Ways to Accelerate Start-Up”
Saturday, Oct. 10 (4:00-5:00 p.m.)

  • Christine Phillips, PhD, Director, Site and Patient Access

“New Methodology for Data Collection: The Digital Patient”
Saturday, Oct. 10 (4:00-5:00 p.m.)

Bringing the site voice to clinical development
As part of its continued commitment to fostering strong site relationships, INC Research is launching a new program at the summit called the “Catalyst Community.” The Catalyst Community is a group of leading sites across the globe that will engage with the Company on an ongoing basis to further develop best practices in clinical research, ultimately bringing increased efficiencies and continuous improvement to the research process. Sites interested in contributing to the discussion and becoming part of INC’s Catalyst Community should visit Booth #33/34.

In addition to launching the Catalyst Community, INC will capitalize on the opportunity to engage the 600+ sites in attendance at the summit in an active dialogue on one of the industry’s most pressing issues: the investigator payment process. Sites will have an opportunity to share their input and add to the discussion on this important topic via an interactive screen and survey at Booth #33/34. INC will close its participation in the summit on Sunday, Oct. 11 with the face-to-face launch of its Site Advocacy Group focused on this very same issue to streamline and enhance the payment process for clinical research sites. The launch of INC’s Investigator Payment Site Advocacy Group follows the kickoff of the Company’s first Site Advocacy Group earlier this year devoted to the scientific and operational aspects of psychiatry protocols. INC is the only CRO to utilize this innovative approach to incorporate the voice of the site early to drive efficiencies in the clinical development process.

Celebrating the contributions of sites at the INC Research Site Appreciation Reception
INC Research will once again host a reception Saturday, Oct. 10 following the SCRS Eagle Awards Gala to recognize and celebrate the vital role sites play in the clinical research process. INC Research CEO Jamie Macdonald; Vice President, Site and Patient Access, Clare Grace, PhD, and INC clinical development executives will be available at the reception to meet with investigators and site personnel to discuss ways to work better together.

INC Research is committed to fostering strong site relationships and has served as a member of and Global Impact Partner to the Society for Clinical Research Sites since 2014. The Company was the society’s first Circle of Sustainability Sponsor, the highest level of partnership with SCRS. INC Research was the first CRO to sponsor SCRS scholarships to provide sites across the globe the benefit of training and mentorship gained through SCRS membership, with 350 scholarships awarded to date. The Company is one of seven finalists for the SCRS 2015 Eagle Award recognizing outstanding leadership, professionalism, integrity, and dedication to advancing the clinical research profession through strong site partnerships.

For more information on INC Research’s commitment to clinical research sites, visit and For more information on the Site Solutions Summit, please visit or

About INC Research
INC Research (Nasdaq:INCR) is a leading global contract research organization (CRO) providing the full range of Phase I to Phase IV clinical development services for the biopharmaceutical and medical device industry. Leveraging the breadth of our service offerings and the depth of our therapeutic expertise across multiple patient populations, INC Research connects customers, clinical research sites and patients to accelerate the delivery of new medicines to market. The Company was ranked “Top CRO to Work With” among large global CROs in the 2015 CenterWatch Global Investigative Site Relationship Survey. INC Research is headquartered in Raleigh, N.C., with operations across six continents and experience spanning more than 100 countries. For more information, please visit

CONTACT: Investor Relations Contact: Ronnie Speight Vice President, Investor Relations Phone: +1 (919) 745-2745 Email: Press/Media Contact: Lori Dorer Senior Director, Corporate Communications Phone: +1 (513) 345-1685 Email: